Department of Ophthalmology, Osaka University Medical School, Suita, Japan.
Am J Ophthalmol. 2010 Nov;150(5):716-725.e1. doi: 10.1016/j.ajo.2010.06.002. Epub 2010 Aug 16.
To explore the incidence and visual outcomes of acute-onset endophthalmitis after transconjunctival microincision vitrectomy surgery (MIVS).
Retrospective, interventional, multicenter survey with a systematic review.
A clinical database search was performed at 27 institutions involving 43 868 consecutive patients who underwent vitrectomy between November 2003 and October 2008 to identify all patients with endophthalmitis after vitrectomy. A systematic review of studies reporting the endophthalmitis rates after MIVS versus 20-gauge vitrectomy was conducted to assess the pooled incidence rates of postvitrectomy endophthalmitis.
The endophthalmitis rates from the multicenter survey were 0.034% (10 cases per 29 030 eyes) after 20-gauge vitrectomy and 0.054% (8 cases per 14 838 eyes) after MIVS, with no significant (P = .603) differences between groups. Although the incidence in 25-gauge cases (6 per 8238 eyes; 0.073%) was greater than in 23-gauge cases (2 per 6600 eyes; 0.030%), the difference was not significant (P = 0.451). Of 8 eyes in which endophthalmitis developed after MIVS, 6 eyes (75%) had a final visual acuity of 0.5 or better, and none lost light perception. By combining the results of 7 studies, including the current multicenter survey, meta-analyses from a total of 77 956 cases at the baseline showed that the pooled endophthalmitis rates after MIVS (0.08%; 95% confidence interval, 0.030% to 0.164%) and after 20-gauge vitrectomy (0.030%; 95% confidence interval, 0.012% to 0.048%) did not differ significantly (P = .207, pooled risk difference; 0.0005 [95% confidence interval, -0.0002 to 0.0012]).
The incidence of postvitrectomy endophthalmitis was low with no significant differences between MIVS and 20-gauge vitrectomy.
探讨经结膜微创玻璃体切除术(MIVS)后急性眼内炎的发生率和视力结果。
回顾性、干预性、多中心调查及系统评价。
在 27 家机构进行临床数据库检索,共纳入 2003 年 11 月至 2008 年 10 月期间接受玻璃体切除术的 43868 例连续患者,以确定所有玻璃体切除术后眼内炎患者。对报告 MIVS 与 20 号auge 玻璃体切除术后眼内炎发生率的研究进行系统评价,以评估玻璃体切除术后眼内炎的总发生率。
多中心研究中,20 号auge 玻璃体切除术后眼内炎发生率为 0.034%(10 例/29030 眼),MIVS 后为 0.054%(8 例/14838 眼),两组间无显著差异(P=0.603)。25 号auge 病例(6 例/8238 眼;0.073%)的发生率高于 23 号auge 病例(2 例/6600 眼;0.030%),但差异无统计学意义(P=0.451)。MIVS 后发生眼内炎的 8 只眼中,6 只(75%)最终视力为 0.5 或更好,无一例丧失光感。结合 7 项研究的结果,包括当前的多中心研究,共有 77956 例患者的基线数据进行的荟萃分析显示,MIVS 后(0.08%;95%置信区间,0.030%至 0.164%)和 20 号auge 玻璃体切除术后(0.030%;95%置信区间,0.012%至 0.048%)的眼内炎总发生率无显著差异(P=0.207,汇总风险差异;0.0005[95%置信区间,-0.0002 至 0.0012])。
玻璃体切除术后眼内炎的发生率较低,MIVS 与 20 号auge 玻璃体切除术之间无显著差异。